3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
3
Thoracic
2
Breast
2
Sarcoma
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Gemcitabine
4
pembrolizumab
3
Docetaxel
3
Cryosurgery
3
Biopsy
3
eribulin
2
durvalumab
2
balstilimab
2
atezolizumab
2
aflibercept
2
Zoledronic Acid
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy
2
Radiosurgery
2
Radiation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Irinotecan
2
Gene Expression Profiling
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
tremelimumab
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Referral and Consultation
×
Sarcoma
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts